Article
Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer
David I. QuinnMitchell E. GrossPulmonary and Respiratory MedicineMarch 3, 2020
Prostate Cancer and Prostatic Diseases
DOI:10.1038/s41391-020-0211-9Keywords:PhenelzineReviews
Join the dialogue
Submit a peer review to improve the scientific record